Injections, Spinal < Injections, Subcutaneous < Inosine Pranobex

Facettes :

List of bibliographic references

Number of relevant bibliographic references: 32.
[0-20] [0 - 20][0 - 32][20-31][20-40]

Ident.	Authors (with country if any)	Title
000203 (2000)	F. Birklein [Allemagne] ; F. Erbguth	Sudomotor testing discriminates between subjects with and without antibodies against botulinum toxin A--a preliminary observation.
000209 (2000)	S A Factor [États-Unis] ; D L Brown ; E S Molho	Subcutaneous apomorphine injections as a treatment for intractable pain in Parkinson's disease.
000327 (2000)	Werner Poewe [Autriche] ; G K Wenning	Apomorphine: an underutilized therapy for Parkinson's disease.
000561 (2001)	H C Wang [Taïwan] ; Y. Hsieh	Treatment of neuroleptic malignant syndrome with subcutaneous apomorphine monotherapy.
000674 (2002)	Petr Kanovsk [République tchèque] ; Dagmar Kubová ; Martin Bares ; Hana Hortová ; Hana Streitová ; Ivan Rektor ; Vladimír Znojil	Levodopa-induced dyskinesias and continuous subcutaneous infusions of apomorphine: results of a two-year, prospective follow-up.
000806 (2002)	Guillermo Paradiso [Canada] ; Farooq Khan ; Robert Chen	Effects of apomorphine on flexor reflex and periodic limb movement.
000B35 (1992)	B. Gomez-Mancilla [Canada] ; R. Boucher ; P J Bédard	Effect of LY 171555 and CY 208-243 on tremor suppression in the MPTP monkey model of parkinsonism.
000D92 (2004)	Andrew H. Evans [Royaume-Uni] ; Regina Katzenschlager ; Dominic Paviour ; John D. O'Sullivan ; Silke Appel ; Andrew D. Lawrence ; Andrew J. Lees	Punding in Parkinson's disease: its relation to the dopamine dysregulation syndrome.
000F61 (2004)	Lisa Jerome ; Rick Doblin ; Michael Mithoefer	Ecstasy use-Parkinson's disease link tenuous.
001010 (2005)	Regina Katzenschlager [Royaume-Uni] ; Andrew Hughes ; Andrew Evans ; Alice J. Manson ; Marion Hoffman ; Lesley Swinn ; Hilary Watt ; Kailash Bhatia ; Niall Quinn ; Andrew J. Lees	Continuous subcutaneous apomorphine therapy improves dyskinesias in Parkinson's disease: a prospective study using single-dose challenges.
001036 (2004)	Svenja Happe [Allemagne] ; Tobias Tings ; Kathrin Helmschmied ; Karin Neubert ; Wolfgang Wuttke ; Walter Paulus ; Claudia Trenkwalder	Levodopa treatment does not affect low-dose apomorphine test in patients with Parkinson's disease.
001040 (2004)	Montse Alegret [Espagne] ; Francesc Valldeoriola ; Majosé Martí ; Manuela Pilleri ; Carme Junqué ; Jordi Rumià ; Eduardo Tolosa	Comparative cognitive effects of bilateral subthalamic stimulation and subcutaneous continuous infusion of apomorphine in Parkinson's disease.
001074 (2005)	Lance A. Smith [Royaume-Uni] ; Michael J. Jackson ; Ghassan Al-Barghouthy ; Sarah Rose ; Mikko Kuoppamaki ; Warren Olanow ; Peter Jenner	Multiple small doses of levodopa plus entacapone produce continuous dopaminergic stimulation and reduce dyskinesia induction in MPTP-treated drug-naive primates.
001465 (1992)	J F De Saint Victor ; P. Pollak ; C L Gervason ; J. Perret	Levodopa-induced diphasic dyskinesias improved by subcutaneous apomorphine.
001467 (1992)	S. Przedborski ; A. Liard ; J. Hildebrand	Induction of mania by apomorphine in a depressed parkinsonian patient.
001610 (2006)	Pedro J. Garcia Ruiz	Nocturnal subcutaneous apomorphine infusion for severe insomnia in Parkinson's disease.
001717 (2006)	Angela Deutschl Nder [Allemagne] ; Friedrich Asmus ; Elena Marelli ; Thomas Klopstock ; Thomas Gasser ; Kai Bötzel	Excellent response to apomorphine in Parkinsonism with optic atrophy unresponsive to oral antiparkinsonian medication.
001744 (2006)	Fredricka C. Martin [États-Unis] ; Adrian Handforth	Carbenoxolone and mefloquine suppress tremor in the harmaline mouse model of essential tremor.
002899 (2009)	Kiyoka Kinugawa ; Emmanuel Itti ; Jean-Francois Lepeintre ; Ivan Mari ; Virginie Czernecki ; Francoise Heran ; Stephane Clemenceau ; Marie Vidailhet ; Emmanuel Roze	Subacute dopa-responsive Parkinsonism after successful surgical treatment of aqueductal stenosis.
002F13 (2011)	Javier Arpa ; Irene Sanz-Gallego ; Josmarlin Medina-Báez ; Luis Valmor Cruz Portela ; Laura Bannach Jardim ; Ignacio Torres-Aleman ; Jonas Alex Morales Saute	Subcutaneous insulin-like growth factor-1 treatment in spinocerebellar ataxias: an open label clinical trial.
004562 (1987)	M. Nomoto [Royaume-Uni] ; S. Stahl ; P. Jenner ; C D Marsden	Antiparkinsonian activity of (+)-PHNO in the MPTP-treated common marmoset.

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Ncbi/Checkpoint

HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Checkpoint/Mesh.i -k "Injections, Subcutaneous" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Checkpoint/Mesh.i  \
                -Sk "Injections, Subcutaneous" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Checkpoint/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    Ncbi
   |étape=   Checkpoint
   |type=    indexItem
   |index=    Mesh.i
   |clé=    Injections, Subcutaneous
}}

---

This area was generated with Dilib version V0.6.23. Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024